Revised Definitions of Invasive Fungal Disease from the European Organization for Research and Treatment of Cancer/Invasive Fungal Infections Cooperative Group and the National Institute of Allergy and Infectious Diseases Mycoses Study Group (EORTC/MSG) Consensus GroupBen de Pauw, John E. Bennett, Thomas J. Walsh et al.|Clinical Infectious Diseases|2008Cited by 4.9k
Clinical Practice Guidelines for the Management of Cryptococcal Disease: 2010 Update by the Infectious Diseases Society of AmericaJohn R. Perfect, Tania C. Sorrell|Clinical Infectious Diseases|2010Cited by 2.7k
Posaconazole vs. Fluconazole or Itraconazole Prophylaxis in Patients with NeutropeniaOliver A. Cornely, D. Angulo-González, Thomas J. Walsh et al.|New England Journal of Medicine|2007Cited by 1.8k
Voriconazole Compared with Liposomal Amphotericin B for Empirical Antifungal Therapy in Patients with Neutropenia and Persistent FeverThomas J. Walsh, Jeanette Lee, Peter G. Pappas et al.|New England Journal of Medicine|2002Cited by 986
Analysis of the Genome and Transcriptome of Cryptococcus neoformans var. grubii Reveals Complex RNA Expression and Microevolution Leading to Virulence AttenuationGuilhem Janbon, Fred S. Dietrich, James A. Fraser et al.|PLoS Genetics|2014Cited by 410